Six Democratic House legislators have sent a letter to US Food and Drug Administration (FDA) Commissioner Robert Califf, MD, asking the agency to take further action on the recent shortage of over-the-counter children's medications for cold and flu, The Hill reports.
Amid an early flu and respiratory syncytial virus (RSV) season in the United States, parents had scrambled to find pain- and fever-relievers such as ibuprofen and acetaminophen for their children. In early February, the FDA released guidelines allowing the compounding of certain oral ibuprofen formulations for hospitals and healthcare systems.
The lawmakers said that while the shortages have eased, supplies haven't been completely replenished. "Despite round-the-clock efforts from manufacturers, demand for these medicines is outpacing supply," they wrote.
The letter signers are Reps. Ro Khanna, Barbara Lee, and Sara Jacobs, all of California; Troy Carter of Louisiana; Bennie Thompson of Mississippi; and Jamaal Bowman of New York.
Despite round-the-clock efforts from manufacturers, demand for these medicines is outpacing supply.
The group proposed three steps that could help alleviate the shortage: giving pharmacists guidance on alternatives to pediatric formulations of ibuprofen and acetaminophen, promoting greater transparency from drug manufacturers about supply locations and demand, and communicating to healthcare providers and parents quickly about the shortage.